Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Journal of Addiction Medicine|September 23, 2022
48-hour Induction of Transdermal Buprenorphine to Sublingual Buprenorphine/Naloxone: The IPPAS MethodPouya Azar, James S H Wong, Nickie Mathew, et al.JAMA Pediatrics|June 6, 2020
Simulated Assessment of Pharmacokinetically Guided Dosing for Investigational Treatments of Pediatric Patients With Coronavirus Disease 2019Anil R Maharaj, Huali Wu, Christoph P Hornik, et al.Journal of Pharmacokinetics and Pharmacodynamics|April 24, 2020
Use of normalized prediction distribution errors for assessing population physiologically-based pharmacokinetic model adequacyAnil R Maharaj, Huali Wu, Christoph P Hornik, et al.Addiction Science & Clinical Practice|June 17, 2024
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorderPouya Azar, Hannah Schneiderman, Henry Barron, et al.Journal of Addiction Medicine|October 17, 2023
48-hour Induction of Transdermal Buprenorphine to Extended-release BuprenorphinePouya Azar, James S H Wong, Nickie Mathew, et al.Frontiers in Pediatrics|November 1, 2021
Characterization of Plasma Protein Alterations in Pregnant and Postpartum Individuals Living With HIV to Support Physiologically-Based Pharmacokinetic Model DevelopmentSherry Zhao, Mary Gockenbach, Manuela Grimstein, et al.Journal of Addiction Medicine|January 9, 2025
Direct Induction of Buprenorphine Extended-Release: A Case ReportPouya Azar, James S H Wong, Jessica Machado, et al.Journal of Clinical Pharmacology|December 10, 2019
Dosing of Continuous Fentanyl Infusions in Obese Children: A Population Pharmacokinetic AnalysisAnil R Maharaj, Huali Wu, Kanecia O Zimmerman, et al.The Journal of Rheumatology|May 13, 2020
Hydroxychloroquine in Patients with Rheumatic Disease Complicated by COVID-19: Clarifying Target Exposures and the Need for Clinical TrialsStephen J Balevic, Christoph P Hornik, Thomas P Green, et al.Journal of Psychoactive Drugs|November 19, 2024
24-Hour Induction of Transdermal Buprenorphine to Buprenorphine Extended-ReleasePouya Azar, Victor W Li, James S H Wong, et al.Pageof 3